Real Chemistry Executive and Leadership Team

Jeffrey O'Connell, the Chief Operating Officer & Chief Technology Officer at Real Chemistry, manages the firm's internal infrastructure and technological roadmap. O'Connell oversees the development of AI-powered platforms that underpin all client services. By integrating operational workflows with advanced data systems, the Chief Operating Officer & Chief Technology Officer ensures seamless service delivery. Jeffrey O'Connell directs the engineering and IT teams to maintain robust, scalable solutions for complex healthcare challenges. This leadership role involves balancing the immediate needs of operational efficiency with the long-term requirements of technological innovation. Through the optimization of internal processes, O'Connell supports the firm's rapid growth and global expansion. The Chief Operating Officer & Chief Technology Officer monitors system performance to guarantee reliability for all partners. By driving digital transformation, O'Connell secures the firm's competitive advantage in the healthcare sector.

Robert Blink, the Group President & Managing Partner at Real Chemistry, oversees the strategic direction of the firm's core business units. Blink manages the performance of large-scale client portfolios to ensure alignment with commercial goals. By fostering deep relationships with key industry stakeholders, the Group President & Managing Partner drives long-term partnership value. Robert Blink directs the expansion of service offerings to meet the evolving demands of the healthcare market. This leadership role involves mentoring senior leaders and promoting a culture of excellence across the organization. Through the application of data-driven insights, Blink optimizes the delivery of healthcare experiences that improve patient outcomes. The Group President & Managing Partner monitors market dynamics to identify new growth opportunities. By providing strategic vision, Blink ensures the firm remains a dominant force in the healthcare services industry.

Elyse Margolis, the Group President At Real Chemistry, leads the strategic development of specialized healthcare communication services. Margolis oversees the integration of scientific expertise with creative marketing to drive client success. By directing cross-functional teams, the Group President At Real Chemistry ensures the delivery of high-impact campaigns that resonate with target audiences. Elyse Margolis manages the growth of key accounts by providing tailored solutions that address specific therapeutic area needs. This leadership role involves collaborating with other executives to refine the firm's service model and market approach. Through the implementation of innovative engagement strategies, Margolis enhances the firm's reputation for excellence. The Group President At Real Chemistry monitors performance metrics to ensure consistent delivery of value. By driving operational success, Margolis supports the firm's mission to transform healthcare experiences.

Elizabeth Beringer, the President & Founder at Real Chemistry, establishes the overarching vision and strategic mission for the organization. Beringer oversees the firm's commitment to creating AI-powered, idea-driven healthcare experiences. By setting the standard for innovation, the President & Founder guides the company's evolution in a rapidly changing market. Elizabeth Beringer directs the executive team to ensure alignment with the core philosophy of putting the customer at the center of every initiative. This leadership role involves championing the firm's culture and driving long-term growth through strategic investments. Through the pursuit of excellence, Beringer maintains the firm's position as a leader in the healthcare services sector. The President & Founder monitors global trends to anticipate future challenges and opportunities. By providing foundational leadership, Beringer ensures the firm continues to deliver exceptional value to healthcare companies worldwide.

Brandon Pletsch, the President, Scientific Visualization at Real Chemistry, directs the creation of advanced visual content that simplifies complex medical data. Pletsch oversees the development of immersive experiences that help healthcare providers and patients understand intricate scientific concepts. By integrating cutting-edge visualization technology with clinical insights, the President, Scientific Visualization enhances the impact of the firm's marketing efforts. Brandon Pletsch leads the creative and technical teams in producing high-fidelity assets that support commercial success. This leadership role involves collaborating with other business units to ensure visual strategies align with broader client goals. Through the application of innovative design, Pletsch elevates the firm's ability to communicate complex information effectively. The President, Scientific Visualization monitors technological advancements to keep the firm at the cutting edge of visual storytelling. By driving creative excellence, Pletsch supports the firm's mission to improve healthcare engagement.

Ericka McKenna, the Chief Marketing Officer at Real Chemistry, drives the global brand strategy and market positioning for the firm. McKenna oversees the development of integrated marketing campaigns that highlight the company's AI-powered capabilities. By analyzing market data, the Chief Marketing Officer crafts narratives that resonate with healthcare decision-makers. Ericka McKenna directs the creative and communications teams to ensure brand consistency across all digital and physical touchpoints. This leadership role involves collaborating with the executive team to align marketing initiatives with long-term business goals. Through the implementation of advanced marketing technology, McKenna optimizes lead generation and client acquisition processes. The Chief Marketing Officer monitors industry shifts to maintain the firm's status as a thought leader. By fostering a culture of innovation, McKenna ensures that the brand remains at the forefront of healthcare marketing.

Michael Otner, the Chief Legal Officer at Real Chemistry, directs all corporate governance and regulatory compliance initiatives. Otner oversees the legal framework governing the use of AI and data in healthcare marketing. By managing risk and ensuring adherence to global healthcare regulations, the Chief Legal Officer protects the firm's reputation and operational integrity. Michael Otner leads the legal team in negotiating complex contracts and partnerships that support the company's commercial objectives. This leadership role involves providing strategic counsel to the board and executive team on matters of intellectual property and data privacy. Through proactive legal planning, Otner enables the firm to innovate within a highly regulated environment. The Chief Legal Officer monitors legislative changes to ensure the company remains compliant across all operating regions. By mitigating legal exposure, Otner supports the firm's sustainable growth.

Allison Gracey, the Managing Director at Real Chemistry, directs high-impact commercial strategies for healthcare clients. Gracey oversees the integration of data-driven insights into client marketing programs to ensure maximum market penetration. By aligning cross-functional teams, the Managing Director optimizes the delivery of AI-powered healthcare experiences. Allison Gracey maintains a focus on scaling client operations across North American markets to drive sustainable growth. This leadership role involves constant collaboration with internal creative units to refine brand messaging. Through the application of advanced analytics, Gracey ensures that every campaign remains centered on the patient experience. The Managing Director monitors performance metrics to adjust tactical execution in real-time. Ultimately, Gracey secures long-term value for partners by bridging the gap between complex medical data and actionable commercial outcomes.

Britt McKone, the Managing Director at Real Chemistry, architects digital transformation initiatives for pharmaceutical partners. McKone manages the deployment of proprietary AI tools to enhance customer engagement strategies. Overseeing the development of omnichannel marketing frameworks, the Managing Director ensures seamless communication across diverse healthcare platforms. Britt McKone drives operational excellence by streamlining internal workflows and fostering innovation within the agency. This leadership role requires deep coordination with technology teams to maintain a competitive edge in the digital health landscape. By prioritizing data integrity and user-centric design, McKone elevates the standard of healthcare communication. The Managing Director evaluates market trends to anticipate client needs and proactively adjust service offerings. Through strategic oversight, McKone strengthens the firm's position as a leader in AI-powered healthcare marketing solutions.

Katie Varnum, the Managing Director at Real Chemistry, leads large-scale commercialization efforts for emerging biotech products. Varnum oversees the strategic planning and execution of launch campaigns that reach global healthcare providers. By leveraging AI-driven analytics, the Managing Director identifies key market opportunities and optimizes resource allocation. Katie Varnum directs the collaboration between medical affairs and commercial teams to ensure consistent messaging across all channels. This leadership role involves managing complex stakeholder relationships to drive adoption of innovative therapies. Through rigorous performance analysis, Varnum refines engagement strategies to improve patient outcomes. The Managing Director maintains a focus on operational efficiency to support rapid market expansion. Ultimately, Varnum delivers measurable commercial success by aligning client objectives with the evolving needs of the healthcare ecosystem.